Androgen receptor antagonist 13
Androgen receptor antagonist 13 (compound 8a) is an orally active Androgen receptor antagonist with an IC50 of 0.20 μM. Androgen receptor antagonist 13 can be used in the study of prostate cancer[1].
Product Specifications
CAS Number
[2558183-91-6]
UNSPSC
12352005
Target
Androgen Receptor
Related Pathways
Vitamin D Related/Nuclear Receptor
Field of Research
Cancer
Smiles
COC1=CC=C(C=C1)S(=O)(NC2=CC=C(C=C2)C3=CC=NN3)=O
Molecular Formula
C16H15N3O3S
Molecular Weight
329.37
References & Citations
[1]Bian C, et al. Design, synthesis and activity evaluation of benzene sulfonamide derivatives as novel androgen receptor antagonist. Eur J Med Chem. 2025 May 5;294:117712.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1399763-01 0.02 mg (E-Coli)
Recombinant Saccharophagus degradans Serine--tRNA ligase (serS)
Ask
View Details 
MBS1399763-02 0.02 mg (Yeast)
Recombinant Saccharophagus degradans Serine--tRNA ligase (serS)
Ask
View Details 
MBS1399763-03 0.1 mg (E-Coli)
Recombinant Saccharophagus degradans Serine--tRNA ligase (serS)
Ask
View Details MBS1399763-04 0.1 mg (Yeast)
Recombinant Saccharophagus degradans Serine--tRNA ligase (serS)
Ask
View Details MBS1399763-05 0.02 mg (Baculovirus)
Recombinant Saccharophagus degradans Serine--tRNA ligase (serS)
Ask
View Details MBS1399763-06 0.02 mg (Mammalian-Cell)
Recombinant Saccharophagus degradans Serine--tRNA ligase (serS)
Ask
View Details